X. Qian

Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.

J. Knowles, M. F. Goy, N. Maeda, 2001, The Biochemical journal.

The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

M. F. Goy, N. Moss, B. Taylor-Blake, 2011, American journal of physiology. Renal physiology.

Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

M. F. Goy, M. Nakazato, N. Moss, 2008, Endocrinology.

Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.

J. Knowles, M. F. Goy, N. Maeda, 2001, The Biochemical journal.

Detection and Related Research of Serum Levels of IL-2, IL-6, IL-8 and ET in Patients with Hyperthyroidism

Zhang Jingyu, L. Hongyan, Wang Cuicui, 2020, Science Journal of Public Health.

Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine.

M. F. Goy, A. Nandi, S. Visweswariah, 2000, Endocrinology.

Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

M. F. Goy, N. Moss, Robert C. Fellner, 2008, Endocrinology.